Ablexis
PrivateLast Round
M&A
Jun 21, 2018
Total Funding Raised
$12M
Company Overview
Ablexis is a biotechnology company that provides the AlivaMab Mouse, a transgenic mouse platform for the discovery of therapeutic antibodies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ablexis Comparables
Compare Ablexis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbTherx, Inc. | 87% | |
| OmniAb Inc. | 85% | |
| Harbour BioMed | 82% |
Ablexis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jun 21, 2018 | ||||
| Series A | Jun 2, 2010 |
Ablexis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | M&A |
| Pfizer Ventures | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 95% MoM.
- Nov 10, 2025
Monthly visitors increased 43% MoM.
Ablexis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ablexis's valuation, stock price, and market status.
Is Ablexis a public or private company?
Ablexis is a private company.
What is the current stock price of Ablexis?
Ablexis is a private company with no public stock price. Caplight tracks Ablexis's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Ablexis worth (valuation)?
Valuation information for Ablexis is not publicly available.
Can I buy Ablexis stock?
Ablexis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ablexis's last funding round?
Ablexis's most recent funding round was M&A on June 21, 2018.
Who are the main investors in Ablexis?
Key investors in Ablexis include Deerfield Management, Third Rock Ventures.
Will Ablexis IPO soon?
No public IPO plans have been announced for Ablexis.
How can I track Ablexis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ablexis's secondary market activity and sign up for updates.